AlphAIAlphAI — Financial news for AI agents
investing.com$TNON

Tenon Medical earnings missed by $0.13, revenue fell short of estimates

Tenon Medical (NASDAQ: TNON) reported Q3 EPS of -$5.39, missing estimates by $0.13, with revenue at $1.4M, below the $1.65M consensus. Shares closed at $1.79, down 65.31% over 3 months and 95.67% over 12 months. InvestingPro rates its financial health as 'fair performance'.

Original reporting
investing.com
Published Nov 12, 2026, 11:37 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 11:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$TNON
Bearish
high confidence
Mentioned
$TNON
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$TNONBearishMed
01

Why it matters

The earnings miss reinforces negative sentiment and may trigger further sell-offs.

02

Market read

Earnings miss for a microcap adds to its downward trajectory, with limited broader market impact.

03

What to watch

Potential upcoming regulatory approvals or contract wins not yet disclosed could offset short-term miss.

Relevance 6/10Novelty 6/10Timing: after-hours

Background

Tenon Medical is a microcap medical device company listed on NASDAQ. The stock has fallen sharply over the past year.

Company-level read

Ticker impact

$TNONBearishHigh confidence
Context

Q3 EPS of $-5.39 missed estimate by $0.13 and revenue of $1.4M fell short of $1.65M consensus.

Expected impact

likely pressure as the market prices in the earnings miss

Evidence & confidence

Both EPS and revenue came in below expectations, reinforcing the stock's recent steep decline.

Market effects

Sector

Microcap medical device sector may see heightened scrutiny on earnings forecasts.

Regional

Limited to U.S. over-the-counter market where TNON trades.

Global

Minimal; impact confined to niche investors.

Counterpoint

What could challenge this read

Some investors may view the deep price decline as a buying opportunity if cash burn stabilizes.

Key entities

  • company
    Tenon Medical

    NASDAQ-listed medical device firm reporting Q3 results.

Read at source← All news

Related articles

$TNONMed

Tenon® Medical Reports Third Quarter 2026 Financial Results

Tenon Medical, Inc. (TNON) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Tenon ® Medical Reports Third Quarter 2026 Financial Results ~ Third Quarter 2026 Revenue of $1.4 Million, a 22% Increase Compared to Prior Year ~ ~ Third Quarter Gross Profit of $1.0 Million, a 23% Increase Compared to Prior Year; Gross Margin of 66.3% ~ ~ Raised Ap

SEC EDGAR 8-K
$TNONHigh

Tenon Medical TNON Jumps As Debt Risk Fades

Tenon Medical Inc. (NASDAQ: TNON) shares surged 53.64% after repaying $5.16M in convertible notes, reducing debt risk. The company reported Q2 2026 revenue of $1.3M, up 127% YoY, with a 64% gross margin. Despite strong growth, TNON faces financial challenges, including a $4.05M net loss and negative equity. Traders are monitoring the stock due to its volatility and recent catalysts, such as FDA clearance and increased surgical volume.

timothysykes.com
$TNONHigh

Tenon Medical TNON Jumps After Early Debt Repayment

Tenon Medical Inc. (TNON) shares rose 55.66% after repaying $5.16M in convertible notes early. The company reported Q2 2026 revenue of $1.3M, up 127% YoY, with a 64% gross margin, but a net loss of $4.05M. TNON's stock is highly volatile, driven by news and liquidity rather than fundamentals.

stockstotrade.com
$TNONHigh

Tenon Medical TNON Stock Jumps As Debt Overhang Vanishes

Tenon Medical Inc. (TNON) stock surged 56.04% on September 11, 2026, following the company's repayment of $5.16M in convertible notes, removing a dilution risk. Q2 revenue grew 127% YoY to $1.3M, with a 64% gross margin, but the company remains unprofitable. TNON regained Nasdaq compliance and reported record surgical case volume.

stockstotrade.com
$TNONHigh

Tenon Medical TNON Jumps As Debt Overhang Clears

Tenon Medical Inc. (TNON) shares rose 55.66% after the company cleared $5.16M in debt ahead of schedule, improving its balance sheet. The stock has shown high volatility, with a recent surge from $2.44 to $5.30. TNON reported Q2 2026 revenue growth of 127% YoY to $1.3M, but remains unprofitable with a net loss of $4.1M. The company secured FDA clearance for a medical device and regained Nasdaq compliance, but faces liquidity challenges and potential future capital raises.

timothysykes.com